A growing shortage of estrogen patches is impacting women across the U.S., potentially disrupting a crucial treatment for managing menopause symptoms. For many women, hormone replacement therapy (HRT) – delivered via patches, pills, or other methods – significantly improves quality of life, reducing hot flashes, night sweats, vaginal dryness, and sleep disturbances.
Demand Surge Drives Shortage
Demand for HRT has risen sharply in recent years. Prescriptions are up 86% since 2021, according to electronic health record data. This surge is partly due to the Food and Drug Administration (FDA) removing a long-standing “black box” warning about HRT risks in November. This change has made many women more willing to consider hormonal options.
Why Patches Are Popular
Estrogen patches are a favored method for HRT because they offer simplicity and bypass the liver, potentially lowering the risk of side effects like blood clots. The transdermal delivery system allows medication to enter the bloodstream directly through the skin, avoiding first-pass metabolism in the liver. This can be a significant advantage for individuals with liver concerns or those seeking a lower-risk approach.
What to Do If Affected
While the shortage is real, several workarounds exist. Women may consider alternative transdermal HRT options, such as gels or sprays, or discuss other forms of estrogen delivery with their healthcare provider. The shortage highlights the growing need for increased HRT production to meet rising demand.
The situation underscores the importance of proactive healthcare management and open communication between patients and their doctors. As demand continues to climb, pharmaceutical companies and healthcare systems must adapt to ensure consistent access to essential treatments.
For more detailed information and expert insights, listen to the latest episode of The Huddle, Women’s Health’s podcast.
